Business finance for veterinary practices

The financial pressures specific to veterinary practice

Veterinary practices face a combination of pressures rarely found in other professional services: high consumable costs (drugs, sutures, anaesthetic agents), expensive capital equipment (ultrasound, digital radiography, in-house laboratory analysers, surgical equipment), and an ethical obligation to provide emergency treatment before the owner has confirmed payment capacity or insurance coverage.

Practices structured as limited companies are eligible for working-capital finance from Credicorp; sole-trader vets and unincorporated partnerships are outside the lending scope. The consolidation of UK veterinary practice into corporate groups has accelerated significantly since 2015, but a large number of independent limited-company practices remain — it is this group for whom this content is relevant.

Drug stock, consumables and the lead-time problem

A veterinary practice is, among other things, a licensed drug supplier and surgical unit. Drug and consumable stock must be purchased from authorised wholesalers, often in minimum quantities, and paid for on wholesaler terms — typically 30 days from invoice. Stock usage is difficult to predict precisely: a busy surgical week or an outbreak of a seasonal condition can deplete stock faster than anticipated, requiring an unplanned reorder that hits cash before the next settlement cycle.

Maintaining an adequate drug and consumable buffer is a clinical obligation as well as a commercial one. A working-capital facility can smooth the mismatch between stock purchase commitments and cash coming in from clients, insurance companies or practice-plan administrators.

Insurance claim timing and payment lags

Where clients have pet insurance, the practice may agree to claim directly from the insurer rather than billing the owner in full at the point of treatment — particularly for complex or expensive procedures. Insurers settle claims on their own timelines, which can be 30–60 days or longer, depending on whether additional clinical documentation is requested. During that period the practice has incurred the drug, consumable and staff cost but has not received full payment.

This dynamic is most acute for referral centres and emergency practices where high-cost procedures are common. A working-capital facility provides the float to bridge insurance claim settlements without disrupting cash available for day-to-day operations.

Equipment investment and practice growth

Adding diagnostic capability — in-house bloods and urinalysis, digital radiography, ultrasound, or endoscopy — requires capital outlay that generates a return over several years rather than weeks. The decision between short-term working capital and longer-term asset finance matters here: for equipment with a long operational life, asset finance spread over that life is usually the more economical structure. Short-term working capital is better suited to bridging a specific gap — covering a deposit, funding consumables while a new piece of equipment beds in, or providing float during an expansion fit-out.

This is general information; your specific decision on equipment finance should be taken with your FD, accountant, or specialist practice finance adviser.

Lending to the company, not the vet personally

Credicorp lends to the limited company, not to the principal vet or director personally. There is no personal guarantee — your personal assets are not pledged against the facility. Assessment focuses on how the practice trades: fee income, client volumes, insurance claims patterns and the company's financial history.

A one-off investment such as a new diagnostic unit or a practice refit suits a business loan with a defined repayment schedule. For the ongoing working-capital rhythm — drug stock, insurance settlement lags, seasonal demand — the revolving Credicorp Flex line gives flexibility to draw when needed and repay as income clears. Figures used here are illustrative ranges, not a quote or an offer.